Combining Traditional Systemic and Biologic Therapies for Psoriasis

The year 2010 marks 8 years since etanercept obtained approval from the Food and Drug
Administration for the treatment of psoriatic arthritis. There are 6 biologic therapies
approved by the Food and Drug Administration for the treatment of psoriasis and/or
psoriatic arthritis. These biologics are often used in patients who have received, are
receiving, or will receive in the future the traditional systemic antipsoriatics. In this article,
the currently available data on combining these therapies are reviewed.
Semin Cutan Med Surg 29:67-69 © 2010 Elsevier Inc. All rights reserved.

The year 2010 marks 8 years since etanercept obtained approval from the Food and Drug
Administration for the treatment of psoriatic arthritis. There are 6 biologic therapies
approved by the Food and Drug Administration for the treatment of psoriasis and/or
psoriatic arthritis. These biologics are often used in patients who have received, are
receiving, or will receive in the future the traditional systemic antipsoriatics. In this article,
the currently available data on combining these therapies are reviewed.
Semin Cutan Med Surg 29:67-69 © 2010 Elsevier Inc. All rights reserved.

Purchase this article:

PURCHASE FOR $25

For unlimited access to all issues and articles:

SUBSCRIBE NOW LOG IN TO ACCOUNT

If you do not subscribe to Seminars in Cutaneous Medicine and Surgery, you may purchase instant access for your personal use. Terms and conditions will apply (see Copyright & Terms of Use). If you need assistance, contact Susan Hite ([email protected]).